Page last updated: 2024-09-05

tbc-11251 and Dyspnea

tbc-11251 has been researched along with Dyspnea in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Safdar, Z1
Hwang, LJ; Jardim, C; Jerjes-Sánchez Díaz, C; Kurzyna, M; Pulido, T; Ramírez, A; Sandoval, J; Souza, R; Teal, SA; Torbicki, A1
Badesch, D; Barst, RJ; Frost, A; Galie, N; Langleben, D; Lawrence, EC; Naeije, R; Shapiro, S1

Trials

2 trial(s) available for tbc-11251 and Dyspnea

ArticleYear
Safety and efficacy of sitaxsentan 50 and 100 mg in patients with pulmonary arterial hypertension.
    Pulmonary pharmacology & therapeutics, 2012, Volume: 25, Issue:1

    Topics: Adolescent; Adult; Aged; Blood Pressure; Child; Dose-Response Relationship, Drug; Double-Blind Method; Dyspnea; Endothelin Receptor Antagonists; Endpoint Determination; Female; Humans; Hypertension, Pulmonary; Intention to Treat Analysis; Isoxazoles; Kaplan-Meier Estimate; Liver Function Tests; Male; Middle Aged; Pulmonary Wedge Pressure; Sample Size; Thiophenes; Treatment Outcome; Vascular Resistance; Young Adult

2012
Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan.
    Journal of the American College of Cardiology, 2006, May-16, Volume: 47, Issue:10

    Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Bosentan; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Dyspnea; Endothelin A Receptor Antagonists; Exercise Test; Exercise Tolerance; Female; Health Status Indicators; Hemodynamics; Humans; Hypertension, Pulmonary; Isoxazoles; Male; Middle Aged; Risk Assessment; Sulfonamides; Thiophenes; Treatment Outcome

2006

Other Studies

1 other study(ies) available for tbc-11251 and Dyspnea

ArticleYear
Effect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertension.
    Vascular health and risk management, 2011, Volume: 7

    Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Drug Substitution; Dyspnea; Edema; Endothelin A Receptor Antagonists; Exercise Test; Exercise Tolerance; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Isoxazoles; Liver Function Tests; Male; Middle Aged; Natriuretic Peptide, Brain; Oxygen; Phenylpropionates; Pyridazines; Retrospective Studies; Texas; Thiophenes; Time Factors; Treatment Outcome; Walking

2011